PHS
CRBU icon

PFM Health Sciences’s Caribou Biosciences CRBU Stock Holding History

PFM Health Sciences’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624K Sell
354,687
-603,100
-63% -$1.19M 0.05% 98
2026
Q1 		$1.82M Hold
957,787
– – 0.17% 79
2025
Q4 		$1.52M Sell
957,787
-401,044
-30% -$842K 0.15% 72
2025
Q3 		$3.17M Hold
1,358,831
– – 0.24% 62
2025
Q2 		$1.71M Sell
1,358,831
-1,147,604
-46% -$1.13M 0.15% 50
2025
Q1 		$2.29M Sell
2,506,435
-1,370,027
-35% -$1.78M 0.17% 53
2024
Q4 		$6.16M Sell
3,876,462
-430,209
-10% -$865K 0.38% 52
2024
Q3 		$8.44M Buy
4,306,671
+223,299
+5% +$457K 0.48% 43
2024
Q2 		$6.7M Sell
4,083,372
-2,399,898
-37% -$7.67M 0.33% 52
2024
Q1 		$33.3M Buy
6,483,270
+2,506
+0% +$15.5K 1.57% 24
2023
Q4 		$37.1M Sell
6,480,764
-243,951
-4% -$1.21M 2.23% 16
2023
Q3 		$32.1M Buy
6,724,715
+1,153,846
+21% +$7.16M 1.51% 29
2023
Q2 		$23.7M Buy
5,570,869
+558,751
+11% +$2.51M 0.92% 44
2023
Q1 		$26.6M Buy
5,012,118
+552,335
+12% +$3.44M 1.18% 37
2022
Q4 		$28M Sell
4,459,783
-1,540,217
-26% -$13.7M 1% 41
2022
Q3 		$63.3M Hold
6,000,000
– – 2.29% 11
2022
Q2 		$32.6M Buy
6,000,000
+1,629,455
+37% +$12.5M 1.24% 37
2022
Q1 		$40.1M Buy
4,370,545
+278,236
+7% +$2.93M 1.5% 29
2021
Q4 		$59.4M Hold
4,092,309
– – 2.02% 15
2021
Q3 		$88.2M Buy
+4,092,309
New +$100M 2.59% 10

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFM Health Sciences's CRBU Position: Q2 2026 in Review

PFM Health Sciences reduced its Caribou Biosciences (CRBU) stake by 63% in Q2 2026, selling an estimated $1.19M and leaving 354,687 shares worth $624K. The position accounts for 0.05% of the portfolio, ranked #98.

PFM Health Sciences first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $88.2M in Q3 2021. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • PFM Health Sciences held 354,687 shares of Caribou Biosciences worth $624K as of Q2 2026.
  • PFM Health Sciences sold 603,100 Caribou Biosciences shares in Q2 2026, an estimated $1.19M.
  • Caribou Biosciences made up 0.05% of PFM Health Sciences's portfolio in Q2 2026, its #98 holding.
  • PFM Health Sciences first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
  • PFM Health Sciences's Caribou Biosciences position peaked at $88.2M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.